Home Tags GW Pharmaceuticals

Tag: GW Pharmaceuticals

hands and an eye abstract art

The Real Reason Cannabis Isn’t Federally Legal

The status of federal legalization in the United States is still a topic of conversation, though more so abroad than at home. Once a...
U.N.-Commission-Removes-Cannabis-from-List-of-Dangerous-Drugs-cannabis-news-mg-Magazine-mgretailer

U.N. Commission Removes Cannabis from List of Dangerous Drugs

VIENNA – The United Nations Commission on Narcotic Drugs, in accordance with 2019 recommendations from the World Health Organization, will remove cannabis from its...
FDA-Approves-Epidiolex-to-Treat-Tuberous-Sclerosis-Seizures-mg-magazine-mgretailer-cannabis-news

FDA Approves Epidiolex to Treat Tuberous Sclerosis Seizures

CARLSBAD, Calif. – Greenwich Biosciences, Inc. and its parent company GW Pharmaceuticals, a British company involved in the development and manufacturing of plant-derived cannabinoid...
Cannabis-Industry-market-crash-2019-mg-magazine-mgretailer

Will the Cannabis Industry Recover from the 2019 Market Crash?

As I write this, a delivery of Animal Cookies is on its way. I’m stocking up, because once I find a consistently reliable product...
epidiolex legal mgretailer

Key DEA Change Could Make Cannabis-Based Medicine More Accessible

Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.  Epidiolex, produced by...
New-Frontier-Town-Hall-mgretailer

Cannabis and Coronavirus: New Frontier Webinar Focuses on Risk, Opportunity

Cannabis marketing data firm New Frontier Data yesterday hosted a day-long webinar on the effect of the coronavirus (COVID-19) crisis on the global cannabis...
end of year mg retailer.jpg

The Year in Review: Cannabis Industry Highlights for 2018

It was quite an eventful year for the cannabis industry. New markets came online, federal laws changed, and the industry became more mainstream than...
GWPharma mgretailer 1

Cost of Cannabis-Based Epilepsy Medication Revealed by Makers

LONDON,UK/CARLSBAD, Calif–GW Pharmaceuticals, makers of newly approved cannabis-based drug Epidiolex, have revealed the estimated annual cost of the medication, which treats two forms of...
Can America Catch Up to Cannabis mg magazine June 2018

Can America Catch Up to Cannabis?

Right now, U.S. federal prohibition on cannabis stands in the way of establishing any comprehensive nationwide policy or real legitimacy for the emerging American...
FDA cannabis joints mg Retailer

FDA Not Likely to Hand out Joints if Medicinal Cannabis Approved

WASHINGTON, D.C. -- With 29 states having already approved the medicinal use of cannabis and an overall rising acceptance of the plant among Americans and...

TOP STORIES